關於 jtocrr ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. JTO Clinical and Research Reports - fatcat.wiki

M. Peravali, I. Joshi, J. Ahn, C. Kim. 2021 | JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2020.100141 pmcid:PMC7790456 ...

#12. JTO Clinical and Research Reports Is Born - ResearchGate

Large single-institution series. ... be found on the JTO CRR website (https://www. editorialmanager.com/jtocrr). ... *Corresponding author. Mayo ...

#13. Somatic and Germline BRCA 1 and 2 Mutations in Advanced ...

https://doi.org/10.1016/j.jtocrr.2020.100068. JTO Clinical and Research Reports Vol. 1 No. 3: 1–11. Page 2. NSCLC were enrolled in the SAFIR02-Lung trial.

#14. JTO Clinical and Research Reports | Elsevier Pharma Solutions

JTO Clinical and Research Reports is the official open access journal of the International Association for the Study of Lung Cancer. It aims to complement.

#15. Journal | JTO Clinical and Research Reports - Scilit

JTO Clinical and Research Reports, Volume 3; https://doi.org/10.1016/j.jtocrr.2022.100328. Open Access. Publisher Website.

#16. Retrospective Evaluation of the Use of Pembrolizumab in ...

creativecommons.org/licenses/by-nc-nd/4.0/). ISSN: 2666-3643 https://doi.org/10.1016/j.jtocrr.2020.100075. JTO Clinical and Research Reports Vol. 1 No.

#17. An Observational Study on Treatment Outcomes in Patients ...

Access to Document. 10.1016/j.jtocrr.2022.100292 ... JTO Clinical and Research Reports, 3(3), [100292]. https://doi.org/10.1016/j.jtocrr.2022.100292.

#18. Medicolegal Considerations in Multidisciplinary Cancer Care.

Medicolegal Considerations in Multidisciplinary Cancer Care.. JTO clinical and research reports, 1(4), 100073. doi:10.1016/j.jtocrr.2020.100073.

#19. JTO Clinical and Research Reports Is Born. - Europe PMC

Logo of jtocrr. JTO Clin Res Rep. 2020 Mar; 1(1): 100014. Published online 2020 Mar 30. doi: 10.1016/j.jtocrr.2020.100014. PMCID: PMC8474459. PMID: 34589916 ...

#20. Treatment for Patients With Early Stage Adenosquamous ...

JTO Clinical and Research Reports Pub Date : 2020-03-04 , DOI: 10.1016/j.jtocrr.2020.100021. Jiaxi He 1, 2, 3, 4 , Shuben Li 2, 3, 4 , Hui Pan 3, ...

#21. Biomarker Testing for People With Advanced Lung Cancer in ...

Biomarker Testing for People With Advanced Lung Cancer in England. JTO Clinical and Research Reports, 2(6), [100176]. https://doi.org/10.1016/j.jtocrr.

#22. PRO Consortium Announces Publication of Open Access Article

... estimates of clinically meaningful within-person change for the NSCLC-SAQ. Access here: https://doi.org/10.1016/j.jtocrr.2022.100298 ...

#23. Biomarker Testing for People With Advanced ... - UCL Discovery

JTO Clinical and Research Reports , 2 (6) , Article 100176. 10.1016/j.jtocrr.2021.100176. Green open access. [thumbnail of 1-s2.0-S2666364321000357-main ...

#24. An Unusual Presentation of a Rare Cancer - University of Iowa

... Alfred Saleh, Patrick J Loehrer and Arun Rajan. JTO clinical and research reports, Vol.1(3), p.100039;. 09/2020;. DOI: 10.1016/j.jtocrr.2020.100039.

#25. Publications | SCRI - Singapore Clinical Research Institute

Published online: December 04, 2021, https://www.jtocrr.org/article/S2666-3643(21)00120-X/fulltext. Asian Thoracic Oncology Research Group Expert Consensus ...

#26. JTO Clinical and Research Reports Archives - MashupMD

Study evaluated EGFR/RET co-existence and pralsetinib distribution in plasma and cerebrospinal fluid https://t.co/Aq7R95DL5F #JTOCRR #LCSM @OncologyAdvance ...

#27. Salvage Surgery for Patients With Local Recurrence or ...

JTO Clinical and Research Reports, 2(5), [100172]. https://doi.org/10.1016/j.jtocrr.2021.100172. Joosten, Pieter J. M. ; Winkelman, ...

#28. Efficacy of Targeted Inhibitors in Metastatic Lung Squamous ...

Access to Document. 10.1016/j.jtocrr.2021.100237 ... JTO Clinical and Research Reports, 2(11), [100237]. https://doi.org/10.1016/j.jtocrr.2021.100237.

#29. JTO Clinical and Research Reports - ResearchPad

10.1016/j.jtocrr.2020.100051. Masanori Fujii, Pedro E.N.S. Vasconcelos, Carol Gergis, Hollis Viray, Andreas Varkaris, Deepa Rangachari, Paul A. VanderLaan, ...

#30. Efficacy and Safety of Rociletinib Versus Chemotherapy in ...

10.1016/j.jtocrr.2020.100114Licence: CC BY-NC-ND · Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLCFinal ...

#31. A Phase 1b Study of Telisotuzumab Vedotin in Combination ...

Access to Document. 10.1016/j.jtocrr.2021.100262 ... JTO Clinical and Research Reports, 3(1), [100262]. https://doi.org/10.1016/j.jtocrr.2021.100262.

#32. Real world approach for molecular analysis of acquired EGFR ...

DOI: 10.1016/j.jtocrr.2021.100252. OpenAccess: Gold. This work has “Gold” OA status. This means it is published in an Open Access journal that is indexed by ...

#33. Current Landscape of Immunotherapy Trials Involving the ...

JTO Clinical and Research Reports, 2(4), [100149]. https://doi.org/10.1016/j.jtocrr.2021.100149. Kareff, Samuel A. ; Samtani, Suraj ; Burotto, ...

#34. Interest in Cessation Treatment Among People Who Smoke in ...

... in a Community-Based Multidisciplinary Thoracic Oncology Program. JTO Clinical and Research Reports. 2021 April. doi: /10.1016/j.jtocrr.2021.100182.

#35. Efficacy and Safety of Glembatumumab Vedotin in Patients ...

Show details for 9 authors. JTO clinical and research reports, Vol.2(5), pp.100166-100166;. 2021-05;. DOI: https://doi.org/10.1016/j.jtocrr.2021.100166.

#36. save - Sci-Hub

◂. sci hub to open science. ↓ save. 10.1016/j.jtocrr.2020.100099.

#37. Mari Mino-Kenudson Archives - ILCN.org (ILCN/WCLC)

Screening via low-dose computed tomography (LDCT) can shift detection to an earlier stage and reduce lung cancer mortality in high-risk... jtocrr.org.

#38. Www.jtocrr.org login - Login page

Are you looking for Www.jtocrr.org login? Now get all the access to your account in one-click using the official links provided below:.

#39. Prognostic Value of Clinical Staging According to TNM in ...

creativecommons.org/licenses/by-nc-nd/4.0/). ISSN: 2666-3643 https://doi.org/10.1016/j.jtocrr.2021.100266. JTO Clinical and Research Reports Vol. 3 No.

#40. Targeting KRAS in Non-Small Cell Lung Cancer - Frontiers

JTO Clin Res Rep (2021) 2(9):100213. doi: 10.1016/j.jtocrr.2021.100213. PubMed Abstract | CrossRef Full Text | Google Scholar. 81. Burslem GM, Crews CM.

#41. International Association for the Study of Lung Cancer | LinkedIn

EGFR+ lung adenocarcinoma http://ow.ly/vr4Z50J7rZ3 #JTOCRR #LCSM. Walang alternatibong paglalarawan ng text para sa larawang ito.

#42. Select Publications | AnHeart Therapeutics

PMID: 34589973 PMCID: PMC8474193 DOI: 10.1016/j.jtocrr.2020.100108. September 2020. Clinical Cancer Research. U.S. Phase I First-in-human Study of ...

#43. 【JTOCRR】中国早期肺腺癌术后患者生存结局——ICAN

ICAN研究PI：吴一龙教授ICAN研究是由广东省人民医院广东省肺癌研究所吴一龙教授牵头的一项全国多中心非干预性研究，此研究主要探索中国手术完全切除的 ...

#44. Taira Ninomaru (0000-0001-5681-1855) - ORCID

DOI: 10.1016/j.jtocrr.2021.100145. Contributors: Taira Ninomaru; Hideaki Okada; Mika Fujishima; Kei Irie; Shoji Fukushima; Akito Hata. Show more detail.

#45. Pre-Clinical — Research News - ALK POSITIVE

JTO Clinical and Research Reports DOI:10.1016/j.jtocrr.2022.100338. Authors: Jie Huang, Shi-Ling Zhang, Chaozheng Zhou, Weiye Huang, Peng Luo, Hua-Jun Chen, ...

#46. 業績 | 先端医療開発センター

Epub 2021年03月18日. doi:10.1016/j.jtocrr.2020.100105. Cited in: Pubmed; PMID 33728415. Watanabe S, Goto Y, Yasuda H, Kohno T, Motoi N, Ohe Y, Nishikawa H, ...

#47. Prognostic Value of Clinical Staging According to TNM ... - VHIR

http://dx.doi.org/10.1016/j.jtocrr.2021.100266. Revista. JTO clinical and research reports. Títol Complet. Prognostic Value of Clinical Staging According to ...

#48. Brief report of Anti-PD1 in HIV setting - HAL-EMSE - CNRS

... in first-line Non Small Cell Lung Cancer therapy. Jto Clinical and Research Reports, Elsevier, 2021, pp.100247. ⟨10.1016/j.jtocrr.2021.100247⟩.

#49. Boosting Lung Cancer Screening Will Improve Survival

2022;3(5):100329. doi:10.1016/j.jtocrr.2022.100329; Pastorino U, Silva M, Sestini S, et al. Prolonged lung cancer screening reduced 10-year ...

#50. Lung cancer with MET exon 14 skipping mutation | LCTT

2020;1(4):100071. doi:10.1016/j.jtocrr.2020.100071. 71. Engstrom L, Aranda R, Lee M, et al. Glesatinib Exhibits Antitumor Activity in Lung ...

#51. Outcomes of Patients With Advanced NSCLC ... - HAL AMU

Identifiants · HAL Id : hal-03430888, version 1 · DOI : 10.1016/j.jtocrr.2020.100052 ...

#52. Horn2021.pdf - International Cancer Advocacy Network

https://doi.org/10.1016/j.jtocrr.2021.100198. JTO Clinical and Research Reports Vol. 2 No. 8: 100198. Page 2. Introduction.

#53. World Journal of Clinical Oncology

[DOI: 10.1016/j.jtocrr.2020.100037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis].

#54. Advances in the Molecular Mechanisms in Gastrointestinal ...

Jto Clin Res Rep (2020) 1(1):1–10. doi: 10.1016/ j.jtocrr.2020.100015 4. Thai AA, Solomon BJ. Treatment of ALK-positive nonsmall cell lung cancer: recent ...

#55. Advances in Precision Medicine Oncology - 第 74 頁 - Google 圖書結果

DOI:https://doi.org/10.1016/j. jtocrr.2020.100075 [26] Scherpereel A, Mazieres J, Greillier L, Lantuejoul S, Dô P, Bylicki O, Monnet I, Corre R, ...

#56. Therapeutic Strategies to Overcome ALK Resistance in Cancer

JTO Clin Res Rep 2020;1:100015. https://doi.org/10.1016/j.jtocrr.2020.100015. [69] Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han Y-C, ...

#57. Cancer Vaccines: Time to Think Differently!

JTO Clin Res Rep (2020) 2:100103. doi: 10.1016/j.jtocrr.2020.100103 67. Jafari F, Javdansirat S, Sanaie S, Naseri A, Shamekh A, Rostamzadeh D, et al.

#58. Advances in Genetics - 第 266 頁 - Google 圖書結果

RET fusion: Joining the ranks of targetable molecular drivers in NSCLC. JTO Clinical and Research Reports, 1(3), 100050. https://doi.org/ 10.1016/j.jtocrr.

#59. Das Hoch- Deutsche ABC.: Nebst einer nuetzlichen Betrachtung ...

50 ®ie ?e()rer/ bic ber JTocrr gefanb, 3>en'n fein ©er^cimmf war bcfant/ folgten ibrem tn'Sreiife unb 51. ^eil aber nun bie "Jettigfeit 76 фа* £оф$етСфе 2l ...